FDA approves Brainsway’s transcranial magnetic stimulator

Israel-based Brainsway has obtained FDA approval for its non-invasive transcranial magnetic stimulation device (Deep TMS) for the treatment of obsessive-compulsive disorder (OCD) in adults, a condition affecting approximately 2 billion people in the US, according to estimates.